CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,613,026 | -22.8% | 835,693 | +19.5% | 0.00% | -50.0% |
Q2 2023 | $5,973,661 | -2.8% | 699,492 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $6,145,114 | -9.9% | 668,674 | +0.1% | 0.00% | 0.0% |
Q4 2022 | $6,820,903 | -29.2% | 668,061 | +2.0% | 0.00% | -33.3% |
Q3 2022 | $9,637,000 | +184.9% | 654,662 | +107.7% | 0.00% | +200.0% |
Q2 2022 | $3,383,000 | +8.3% | 315,256 | +8.8% | 0.00% | 0.0% |
Q1 2022 | $3,125,000 | +81.1% | 289,846 | +174.2% | 0.00% | 0.0% |
Q4 2021 | $1,726,000 | -21.8% | 105,704 | +2.6% | 0.00% | 0.0% |
Q3 2021 | $2,206,000 | – | 102,990 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
Miura Global Management | 780,000 | $7,963,800 | 4.01% |
RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |